A Multi-Center, Phase 3b, Stratified, Randomized, Open-Label Clinical Trial to Evaluate the Efficacy of Intensive Apidra/Lantus Therapy vs Sliding Scale Insulin on Infarct Size in Hyperglycemic Subjects With Anterior STEMI (ST Elevation Myocardial Infarction) Undergoing PCI (Percutaneous Coronary Intervention).

Trial Profile

A Multi-Center, Phase 3b, Stratified, Randomized, Open-Label Clinical Trial to Evaluate the Efficacy of Intensive Apidra/Lantus Therapy vs Sliding Scale Insulin on Infarct Size in Hyperglycemic Subjects With Anterior STEMI (ST Elevation Myocardial Infarction) Undergoing PCI (Percutaneous Coronary Intervention).

Discontinued
Phase of Trial: Phase III

Latest Information Update: 10 Feb 2011

At a glance

  • Drugs Insulin; Insulin glargine; Insulin glulisine
  • Indications Hyperglycaemia; Myocardial infarction
  • Focus Pharmacodynamics
  • Acronyms INTENSIVE
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 22 Jan 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 15 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top